9th Circuit Says FDA Rightly Banned Vape Companies’ E-Liquids

Attached Documents

• Opinion
• Lotus’ opening brief
• FDA’s answering brief
• Lotus’ reply brief
• 38 e-cigarette advocacy organizations’ amicus brief
• Health experts’ amicus brief
• Public health groups’ amicus brief
• FDA’s July 19, 2022, supplemental authority
• Lotus’ response to July 19 supplemental authority
• FDA’s July 29, 2022, supplemental authority
• Lotus’ response to July 29 supplemental authority
• Lotus’ Aug. 25, 2022, supplemental authority
• FDA’s Sept. 7, 2022, supplemental authority
• FDA’s response to Aug. 25 supplemental authority
• Lotus’ response to Sept. 7 supplemental authority
• Lotus’s motion for judicial notice
• FDA’s opposition
• Lotus’ reply
• FDA’s Oct. 31, 2022, supplemental authority
• FDA’s Dec. 15, 2022, supplemental authority
• Lotus’ second motion for judicial notice
• FDA’s opposition
• Lotus’s reply
• Lotus’ response to Dec. 15 supplemental authority
• FDA’s Jan. 19 supplemental authority
• Lotus’ third motion for judicial notice
• FDA’s opposition
• Lotus’ reply
• Lotus’ March 26 supplemental authority
• FDA’s response to March 26 supplemental authority
• FDA’s April 20 supplemental authority
• FDA’s May 17 supplemental authority
• Lotus’ response to April 20 supplemental authority
• Lotus’ response to May 17 supplemental authority
• Lotus’ June 2 supplemental authority
• FDA’s response to June 2 supplemental authority
• FDA’s June 23 supplemental authority
• Lotus’ response to June 23 supplemental authority
• Nude’s opening brief
• FDA’s answering brief (No. 21-71321)
• Nude’s reply brief
• Nude’s Sept. 4, 2022, supplemental authority
• Lotus’ petition for review with Sept. 17, 2021, MDO attached
• Nude’s petition for review with Sept. 7, 2021, MDO attached